Baby-food maker Gerber is being accused by the government of falsely claiming that its Good Start Gentle formula can prevent or reduce allergies in children.
In a complaint filed Thursday in federal court, the Federal Trade Commission alleged that the company misled consumers by suggesting that its formula was the first to meet government approval for reducing the risk of allergies.
The FTC said it wants Gerber to pull its claim from labels and advertisements, and left open the possibility of asking the court to require Gerber to issue refunds for the $20-plus packages sold since 2011.
Gerber Products Co., also doing business as Nestlé Infant Nutrition, said it didn’t violate the law.
“We are defending our position because we believe we have met, and will continue to meet, all legal requirements to make these product claims,” said Kevin Goldberg, vice president and general counsel for the New Jersey-based company.
At issue is how far Gerber went when claiming that its formula could prevent one type of allergy in infants known as atopic dermatitis, a skin rash also known as baby eczema.
According to the FTC, Gerber had petitioned the Food and Drug Administration in 2009 for permission to connect its use of partially hydrolyzed whey proteins to reducing atopic dermatitis. The FDA agreed, but only if Gerber qualified its statement by making clear that there was “little scientific evidence” for the relationship.
Instead, packages of Good Start Gentle formula in 2011 suggested it was the first formula approved by the FDA to reduce the risk that a baby would develop allergies in general. No qualifier was included, and the labels could easily be interpreted to mean that the formula could prevent a child from developing life-threatening food or environmental allergies.
“I love mommy’s eyes, not her allergies,” said one advertisement, released by the FTC.
“Parents trusted Gerber to tell the truth about the health benefits of its formula, and the company’s ads failed to live up to that trust,” said Jessica Rich, director of the FTC’s bureau of consumer protection. “Gerber didn’t have evidence to back up its claim that Good Start Gentle formula reduces the risk of babies developing their parents’ allergies.”
In its statement, released Thursday, Gerber reiterated the claim that its formula can help prevent baby eczema, and said the company had been authorized by the FDA to feature that claim.
“Gerber always has and will continue to treat its mission of delivering nutrition and benefits to infants as its top priority,” Goldberg wrote. “We believe the information conveyed in our marketing is important for parents who have children at risk for atopic dermatitis, the most common allergy in infancy.”
With Gerber suggesting that it refuses to settle, the case will likely be decided by a district court in New Jersey, where Gerber’s headquarters are located.
An FTC spokesman said the agency hasn’t determined yet whether consumer refunds might be necessary.